NCT03868111View on ClinicalTrials.gov

Sufentanil as Adjuvant of Balanced Anesthesia

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

January 12, 2020

Study Completion Date

January 12, 2020

Conditions
Anesthesia
Interventions
DRUG

Sufentanil

The infusion rate of sufentanil is adjusted to achieve a surgical pleth index of 20-50 throughout the operative time.

DRUG

Remifentanil

The infusion rate of remifentanil is adjusted to achieve a surgical pleth index of 20-50 throughout the operative time.

Trial Locations (1)

03181

Kangbuk Samsung Hospital, Seoul

All Listed Sponsors
lead

Kangbuk Samsung Hospital

OTHER

NCT03868111 - Sufentanil as Adjuvant of Balanced Anesthesia | Biotech Hunter | Biotech Hunter